T1	Participants 140 169	Minority patients with cancer
T2	Participants 310 327	minority patients
T3	Participants 505 626	Sixty-seven English-speaking adult cancer outpatients, including 15 minorities, with moderate pain over the prior 2 weeks
T4	Participants 1166 1183	minority patients
